135 related articles for article (PubMed ID: 28151653)
1. Full Sequence Amino Acid Scanning of θ-Defensin RTD-1 Yields a Potent Anthrax Lethal Factor Protease Inhibitor.
Li Y; Gould A; Aboye T; Bi T; Breindel L; Shekhtman A; Camarero JA
J Med Chem; 2017 Mar; 60(5):1916-1927. PubMed ID: 28151653
[TBL] [Abstract][Full Text] [Related]
2. In-cell production of a genetically-encoded library based on the θ-defensin RTD-1 using a bacterial expression system.
Bi T; Li Y; Shekhtman A; Camarero JA
Bioorg Med Chem; 2018 Mar; 26(6):1212-1219. PubMed ID: 28927803
[TBL] [Abstract][Full Text] [Related]
3. Efficient one-pot cyclization/folding of Rhesus θ-defensin-1 (RTD-1).
Aboye TL; Li Y; Majumder S; Hao J; Shekhtman A; Camarero JA
Bioorg Med Chem Lett; 2012 Apr; 22(8):2823-6. PubMed ID: 22425570
[TBL] [Abstract][Full Text] [Related]
4. Recombinant production of rhesus θ-defensin-1 (RTD-1) using a bacterial expression system.
Gould A; Li Y; Majumder S; Garcia AE; Carlsson P; Shekhtman A; Camarero JA
Mol Biosyst; 2012 Apr; 8(4):1359-65. PubMed ID: 22327102
[TBL] [Abstract][Full Text] [Related]
5. Theta-defensins: cyclic antimicrobial peptides produced by binary ligation of truncated alpha-defensins.
Selsted ME
Curr Protein Pept Sci; 2004 Oct; 5(5):365-71. PubMed ID: 15544531
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structure of RTD-1, a cyclic antimicrobial defensin from Rhesus macaque leukocytes.
Trabi M; Schirra HJ; Craik DJ
Biochemistry; 2001 Apr; 40(14):4211-21. PubMed ID: 11284676
[TBL] [Abstract][Full Text] [Related]
7. Efficient Enzymatic Cyclization of Disulfide-Rich Peptides by Using Peptide Ligases.
Schmidt M; Huang YH; Texeira de Oliveira EF; Toplak A; Wijma HJ; Janssen DB; van Maarseveen JH; Craik DJ; Nuijens T
Chembiochem; 2019 Jun; 20(12):1524-1529. PubMed ID: 30735312
[TBL] [Abstract][Full Text] [Related]
8. QSAR and molecular docking studies of lethal factor protease inhibitors against
Saxena M; Nandi S; Saxena AK
SAR QSAR Environ Res; 2019 Oct; 30(10):715-731. PubMed ID: 31556709
[No Abstract] [Full Text] [Related]
9. Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides.
Tran D; Tran PA; Tang YQ; Yuan J; Cole T; Selsted ME
J Biol Chem; 2002 Feb; 277(5):3079-84. PubMed ID: 11675394
[TBL] [Abstract][Full Text] [Related]
10. Yeast-hybrid based high-throughput assay for identification of anthrax lethal factor inhibitors.
Kim J; Park HC; Gedi V; Park HY; Roberts AG; Atkins WM; Yoon MY
Biochem Biophys Res Commun; 2011 Jan; 404(1):517-22. PubMed ID: 21144836
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of anthrax lethal factor: lability of hydroxamate as a chelating group.
Li F; Chvyrkova I; Terzyan S; Wakeham N; Turner R; Ghosh AK; Zhang XC; Tang J
Appl Microbiol Biotechnol; 2012 May; 94(4):1041-9. PubMed ID: 22270239
[TBL] [Abstract][Full Text] [Related]
12. Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies.
Johnson SL; Jung D; Forino M; Chen Y; Satterthwait A; Rozanov DV; Strongin AY; Pellecchia M
J Med Chem; 2006 Jan; 49(1):27-30. PubMed ID: 16392787
[TBL] [Abstract][Full Text] [Related]
13. Effects of metalloprotease anthrax lethal factor on its peptide-based inhibitor R9LF-1.
Kong Q; Song Y; Mu M; Han X; Si C; Li F
Mol Cell Biochem; 2015 Aug; 406(1-2):293-9. PubMed ID: 25981534
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of the Metalloproteinase Anthrax Lethal Factor.
Goldberg AB; Turk BE
Curr Top Med Chem; 2016; 16(21):2350-8. PubMed ID: 27072692
[TBL] [Abstract][Full Text] [Related]
15. The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.
Xiong Y; Wiltsie J; Woods A; Guo J; Pivnichny JV; Tang W; Bansal A; Cummings RT; Cunningham BR; Friedlander AM; Douglas CM; Salowe SP; Zaller DM; Scolnick EM; Schmatz DM; Bartizal K; Hermes JD; MacCoss M; Chapman KT
Bioorg Med Chem Lett; 2006 Feb; 16(4):964-8. PubMed ID: 16338135
[TBL] [Abstract][Full Text] [Related]
16. A high-throughput screening approach to anthrax lethal factor inhibition.
Johnson SL; Chen LH; Pellecchia M
Bioorg Chem; 2007 Aug; 35(4):306-12. PubMed ID: 17320146
[TBL] [Abstract][Full Text] [Related]
17. Stop the killer: how to inhibit the anthrax lethal factor metalloprotease.
Montecucco C; Tonello F; Zanotti G
Trends Biochem Sci; 2004 Jun; 29(6):282-5. PubMed ID: 15276179
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of anthrax lethal factor.
Gaddis BD; Avramova LV; Chmielewski J
Bioorg Med Chem Lett; 2007 Aug; 17(16):4575-8. PubMed ID: 17574849
[TBL] [Abstract][Full Text] [Related]
19. The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor.
Turk BE; Wong TY; Schwarzenbacher R; Jarrell ET; Leppla SH; Collier RJ; Liddington RC; Cantley LC
Nat Struct Mol Biol; 2004 Jan; 11(1):60-6. PubMed ID: 14718924
[TBL] [Abstract][Full Text] [Related]
20. Mixed-type noncompetitive inhibition of anthrax lethal factor protease by aminoglycosides.
Kuzmic P; Cregar L; Millis SZ; Goldman M
FEBS J; 2006 Jul; 273(13):3054-62. PubMed ID: 16817854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
